Claria Medical, Inc.
Tissue Containment and Extraction System (TCES) for minimally invasive surgical removal of large organs
- Sector
- Medtech
- Headquarters
- Mountain View, CA
- Founded
- 2017
- Latest Form D
- $4.5M, Jun 2021
- Total capital
- $10.3M
- Federal grants
- $5.2M
- 5 awards · 2020–2025
- Rank in peer group#63 of 538
- Private capital raised
- $5M
- 4 Form D · last Jun 2021
- 65 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 19 pending · first 2020
- Rank in peer group#158 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · A Safe, Fast, and Cost-Effective System for Tissue Removal in Laparoscopic Hysterectomy and Other Minimally Invasive Surgery$2.1M
- Federal grantHealth and Human S · Phase II · A Safe, Fast, and Cost-Effective System for Tissue Removal in Laparoscopic Hysterectomy and Other Minimally Invasive Surgery$142K
- Federal grantHealth and Human S · Phase II · A Safe, Fast, and Cost-Effective System for Tissue Removal in Laparoscopic Hysterectomy and Other Minimally Invasive Surgery$1.7M
- Federal grantNSF · Phase II · SBIR Phase II:A Safe, Fast, and Cost-Effective System for Tissue Removal in Laparoscopic Transabdominal Hysterectomy and Myomectomy$1M
- Private capital raisedForm D · SEC · 4th filing$4.5M
- Federal grantNSF · Phase I · SBIR Phase I:A Safer, Faster, Simpler and More Cost-Effective System for Tissue Removal in Laparoscopic Hysterectomy and Other Minimally Invasive Surgery$256K
- Private capital raisedForm D · SEC · 3rd filing$75K
- Private capital raisedForm D · SEC · 2nd filing$125K
- Private capital raisedForm D · SEC · 1st filing$373K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#63 · top 12%
- Granted patents#158 · top 29%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Steven KimResearcherDirectorLinked by 3 patents
- Alexey SalaminiExecutive Officer, DirectorNamed in SEC Form D filings
- Anthony XuDirectorNamed in SEC Form D filings
- Joseph Marchesani JonesDirectorNamed in SEC Form D filings
- Joseph MarchesaniDirectorNamed in SEC Form D filings
- Mira Marchesani SahneyDirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 22- PendingSystems And Methods For Tissue Capture And RemovalUSPTOApplication 19259081
- GrantedSystems And Methods For Tissue Capture And RemovalUSPTOUS 12,349,939
- PendingTissue Removal Systems And MethodsUSPTOApplication 18848871
Show all 22 patent records
- Systems And Methods For Tissue Capture And RemovalOct 23, 2025 · Application 19259081Pending
- Systems And Methods For Tissue Capture And RemovalJul 8, 2025 · US 12,349,939Granted
- Tissue Removal Systems And MethodsJul 3, 2025 · Application 18848871Pending
- Tissue Removal Systems And MethodsApr 17, 2025 · Application 19000419Pending
- Tissue Removal Systems And MethodsApr 17, 2025 · Application 19000464Pending
- Systems And Methods For Tissue Capture And RemovalSep 27, 2022 · US 11,452,546Granted
- Tissue Removal Systems And MethodsSep 1, 2022 · Application 17634941Pending
- Systems And Methods For Tissue Capture And RemovalAug 13, 2020 · Application 16758358Pending
- Systems And Methods For Tissue Capture And RemovalJun 30, 2020 · US 10,695,091Granted
- Tissue Removal Systems And MethodsApplication 63325116Pending
- Tissue Removal Systems And MethodsApplication 63323977Pending
- Tissue Removal Systems And MethodsApplication 63358050Pending
- Tissue Removal Systems And MethodsApplication PCTUS2020046135Pending
- Tissue Removal Systems And MethodsApplication PCTUS2023016158Pending
- Tissue Removal Systems And MethodsApplication 63006360Pending
- Tissue Removal Systems And MethodsApplication 62886473Pending
- Systems And Methods For Tissue Capture And RemovalApplication PCTUS2018056915Pending
- Systems And Methods For Tissue Capture And RemovalApplication 62576019Pending
- Systems And Methods For Tissue Capture And RemovalApplication PCTUS2017029162Pending
- Tissue Removal Systems And MethodsApplication 63350319Pending
- Systems and methods to improve specimen captureApplication 62326836Pending
- Tissue Removal Systems And MethodsApplication 63332623Pending
Related companies, and why
- ADEPTRIX CORPSimilar federal contract value in Medtech · null in contracts
- OtoNexus Medical Technologies, Inc.Similar federal contract value in Medtech · null in contracts
- YONA CARE LLCSimilar federal contract value in Medtech · null in contracts
- Amplified Sciences, LLCSimilar federal contract value in Medtech · null in contracts
- Forest Devices, IncSimilar federal contract value in Medtech · null in contracts
- SEACOAST SCIENCE, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .